In: Clinical and Translational Oncology, 2014, vol. 16, no. 1, p. 85-90
|
In: Virchows Archiv, 2004, vol. 444, no. 3, p. 264-268
|
In: European Radiology, 2011, vol. 21, no. 4, p. 857-862
|
In: Annals of Hematology, 2010, vol. 89, no. 6, p. 569-577
|
In: The Journal of Laryngology & Otology, 1998, vol. 112, no. 5, p. 469-471
|
In: Journal of Translational Medicine, 2014, vol. 12, no. 1, p. 119
Background: Multiple myeloma is characterized by clonal expansion of B cells producing monoclonal immunoglobulins or fragments thereof, which can be detected in the serum and/or urine and are ideal target antigens for patient-specific immunotherapies.Methods: Using phage particles as immunological carriers, we employed a novel chemically linked idiotype vaccine in a clinical phase I/II trial...
|